SCHEMBL16410844

SCHEMBL16410844

NN1c2cc(Cl)c(Cl)cc2N=C(N=NCc2ccccc2)C12CCCCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410566 0.84 SLC6A4 (0.33) —
SCHEMBL16410760 0.84 — —
SCHEMBL16410823 0.80 AMPD2 (0.34) —
SCHEMBL16410685 0.75 TSHR (0.33) —
SCHEMBL16410847 0.73 ACAT2 (0.37) —
SCHEMBL16410813 0.73 AMPD2 (0.33) —
SCHEMBL16410780 0.71 MEN1 (0.35) —
SCHEMBL16410869 0.71 GAA (0.33) —
SCHEMBL16410625 0.70 GRIN2B (0.34) —
SCHEMBL16410631 0.70 ACAT2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback